Telmiaplus Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
MFDS item code 201902127 · Approved 2019.04.08
This product's status changed to Expired on 2024.04.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement in blood pressure control for essential hypertension
This medication may be effective for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan. In such cases, the two drugs can be combined to lower blood pressure more stably. This helps reduce the risk of complications associated with hypertension. Patients who find it difficult to manage their blood pressure can also expect positive effects on blood pressure control with continuous use. This medication is specifically used for the treatment of essential hypertension.
The recommended dose of this medication is one tablet once a day, to be taken with water regardless of meals. It is advisable to take it at the same time each day (e.g., in the morning). Dosing guidelines are available for 40/5 mg, 80/5 mg, and 40/10 mg, and separate dosing adjustments and caution are necessary for patients with kidney impairment, liver dysfunction, and the elderly.
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, so its use is not recommended.
This medication can pose serious risks to the fetus, especially during the 2nd and 3rd trimester of pregnancy, and should not be taken by pregnant women or women who may become pregnant. Use of this medication is contraindicated or requires caution for patients with certain conditions. For example, patients with liver disorders, severe hypotension, cardiac diseases, obstructive biliary diseases, and those with severely impaired kidney function or diabetes should not use this medication. As this medication lowers blood pressure, it may cause hypotension, and if symptoms of hypotension occur, appropriate measures should be taken immediately. Furthermore, there is a risk of hyperkalemia, which is an increase in potassium levels in the blood, so potassium levels should be regularly checked, and caution should be taken when combining with medications or supplements high in potassium. For patients with reduced kidney function, there is a risk of worsening renal function, and serum creatinine and potassium levels should be monitored periodically. Side effects such as dizziness, drowsiness, visual disturbances, palpitations, and edema can commonly occur, and care should be taken when driving or operating machinery. Since this medication has a strong blood pressure-lowering effect, patients with cardiovascular diseases should be cautious as excessive blood pressure reduction may increase the risk of myocardial infarction or stroke. This medication may interact with other drugs, so patients should inform their doctor or pharmacist if they are taking other medications, especially when used with lithium, digoxin, warfarin, non-steroidal anti-inflammatory drugs, etc. Pregnant or breastfeeding women should not take this medication and must stop immediately if pregnancy is confirmed. The safety and efficacy of this medication in pediatric patients have not been sufficiently established, so it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and cardiac abnormalities may occur, and prompt medical attention should be sought. This medication should be kept out of reach of children, and it is advisable not to transfer it to other containers to maintain the product's quality.
Severe allergic reactions (hives, angioedema), severe skin reaction (severe rash, blisters, skin peeling, pain in mucous membranes of the mouth/eyes), respiratory problems (difficulty breathing), liver abnormalities (jaundice, hepatitis, elevated liver enzymes), serious neurological symptoms (severe headache, fainting, altered consciousness, visual disturbances, paralysis), severe edema or urination problems (kidney dysfunction, acute renal failure, severe edema accompanied by increased blood pressure), sepsis, myocardial infarction, heart
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it should be kept at room temperature, not too hot or too cold, between 1 to 30 degrees Celsius.
This is a white and light gray double tablet that is convex on both sides.
30 tablets/PTP [30 tablets (10 tablets/Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.